BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16298621)

  • 21. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
    Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
    Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
    Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.
    Nakazawa Y; Saito S; Hasegawa Y; Yanagisawa R; Sakashita K; Kamijo T; Miyazaki T; Sato S; Ikeda H; Ikebuchi K; Koike K
    Transfusion; 2007 Feb; 47(2):326-34. PubMed ID: 17302780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High risk of sensitization after failed islet transplantation.
    Campbell PM; Senior PA; Salam A; Labranche K; Bigam DL; Kneteman NM; Imes S; Halpin A; Ryan EA; Shapiro AM
    Am J Transplant; 2007 Oct; 7(10):2311-7. PubMed ID: 17845564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts.
    Hilbrands R; Gillard P; Van der Torren CR; Ling Z; Verheyden S; Jacobs-Tulleneers-Thevissen D; Roep BO; Claas FH; Demanet C; Gorus FK; Pipeleers D; Keymeulen B
    Transplantation; 2013 Jul; 96(2):162-9. PubMed ID: 23857001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
    Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
    Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA incompatibility and immunogenicity of human pancreatic islet preparations cocultured with blood cells of healthy donors.
    Bouwman LH; Ling Z; Duinkerken G; Pipeleers DG; Roep BO
    Hum Immunol; 2005 May; 66(5):494-500. PubMed ID: 15935886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful islet transplantation to two recipients from a single donor by targeting proinflammatory cytokines in mice.
    Satoh M; Yasunami Y; Matsuoka N; Nakano M; Itoh T; Nitta T; Anzai K; Ono J; Taniguchi M; Ikeda S
    Transplantation; 2007 Apr; 83(8):1085-92. PubMed ID: 17452899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts.
    Heinemann FM; Roth I; Rebmann V; Arnold ML; Witzke O; Wilde B; Spriewald BM; Grosse-Wilde H
    Hum Immunol; 2007 Jun; 68(6):500-6. PubMed ID: 17509449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of kidney transplant failure and antibodies against MICA.
    Mizutani K; Terasaki P; Bignon JD; Hourmant M; Cesbron-Gautier A; Shih RN; Pei R; Lee J; Ozawa M
    Hum Immunol; 2006 Sep; 67(9):683-91. PubMed ID: 17002898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term graft function after allogeneic islet transplantation.
    Lakey JR; Kin T; Warnock GL; Shapiro AM; Tsapogas P; Imes S; Korbutt GS; Kneteman NM; Rajotte RV; Ryan EA
    Cell Transplant; 2007; 16(4):441-6. PubMed ID: 17658134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte antigen mismatch and other factors affecting cryopreserved allograft valve function.
    Yap CH; Skillington PD; Matalanis G; Davis BB; Tait BD; Hudson F; Ireland L; Nixon I; Yii M
    Heart Surg Forum; 2008; 11(1):E42-5. PubMed ID: 18270140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of class I-directed lymphocytotoxic antibodies after liver transplantation.
    Bryan CF; Newman JT; Tillquist RL; Husberg B; Klintmalm GB; Stone MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2392-3. PubMed ID: 3274523
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.